ADIPOQ and Insulin resistance: Previous studies in non-acromegalic humans were focused to investigate fasting levels and/or regulation of circulating GH concentrations with regard to anthropometric measures and/or mere indicators of insulin resistance, such as hyperinsulinemia, adiponectin concentrations and subclinical inflammation markers [5]–[15].